Matthew Burton
Chandler, AZNPI 1518426972
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations.
Across 166 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$491
- Sunovion Pharmaceuticals Inc.$375
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$307
- Avanir Pharmaceuticals, Inc.$258
- Otsuka America Pharmaceutical, Inc.$214
- Takeda Pharmaceuticals U.S.A., Inc.$211
- plus $935 from 13 others
What the payments were for
- Food & beverage$2,73298%
- Education$582%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $491 |
| Sunovion Pharmaceuticals Inc. | 21 | $375 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $307 |
| Avanir Pharmaceuticals, Inc. | 20 | $258 |
| Otsuka America Pharmaceutical, Inc. | 12 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $211 |
| Alkermes, Inc. | 8 | $182 |
| Lundbeck LLC | 11 | $163 |
| Supernus Pharmaceuticals, Inc. | 5 | $101 |
| Eisai Inc. | 6 | $96 |
| Bausch Health US, LLC | 5 | $84 |
| Vanda Pharmaceuticals Inc. | 4 | $84 |
| Neurocrine Biosciences, Inc. | 3 | $67 |
| Alfasigma USA, Inc. | 3 | $40 |
| Johnson & Johnson | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Biogen | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $13 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.